Free Trial

Iofina (IOF) Competitors

Iofina logo
GBX 24.82 +1.83 (+7.93%)
As of 11:25 AM Eastern

IOF vs. TET, SYNT, HAYD, WCH, ITX, DCTA, HDD, BIOM, VRS, and ZED

Should you be buying Iofina stock or one of its competitors? The main competitors of Iofina include Treatt (TET), Synthomer (SYNT), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Hardide (HDD), Biome Technologies (BIOM), Versarien (VRS), and Zenova Group (ZED). These companies are all part of the "specialty chemicals" industry.

Iofina vs. Its Competitors

Treatt (LON:TET) and Iofina (LON:IOF) are both small-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, risk, analyst recommendations and media sentiment.

42.1% of Treatt shares are held by institutional investors. Comparatively, 0.5% of Iofina shares are held by institutional investors. 4.1% of Treatt shares are held by insiders. Comparatively, 13.4% of Iofina shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Iofina had 2 more articles in the media than Treatt. MarketBeat recorded 2 mentions for Iofina and 0 mentions for Treatt. Treatt's average media sentiment score of 0.00 equaled Iofina'saverage media sentiment score.

Company Overall Sentiment
Treatt Neutral
Iofina Neutral

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Treatt£145.16M1.04£11.22M£0.181,390.40
Iofina£57.65M0.83£4.28M£0.03993.00

Treatt currently has a consensus price target of GBX 266.67, suggesting a potential upside of 4.58%. Iofina has a consensus price target of GBX 40, suggesting a potential upside of 61.13%. Given Iofina's stronger consensus rating and higher possible upside, analysts clearly believe Iofina is more favorable than Treatt.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Treatt
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
Iofina
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Treatt has a net margin of 7.88% compared to Iofina's net margin of 6.98%. Treatt's return on equity of 8.09% beat Iofina's return on equity.

Company Net Margins Return on Equity Return on Assets
Treatt7.88% 8.09% 6.72%
Iofina 6.98%8.00%5.18%

Treatt has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, Iofina has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500.

Summary

Treatt beats Iofina on 10 of the 14 factors compared between the two stocks.

Get Iofina News Delivered to You Automatically

Sign up to receive the latest news and ratings for IOF and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IOF vs. The Competition

MetricIofinaSpecialty Chemicals IndustryMaterials SectorLON Exchange
Market Cap£47.63M£7.38B£3.86B£2.58B
Dividend Yield2.88%3.48%5.05%5.32%
P/E Ratio993.00633.14160.114,414.47
Price / Sales0.8397.9426,544.68100,817.46
Price / Cash7.9619.2526.8927.90
Price / Book1.112.917.428.26
Net Income£4.28M£220.83M£148.99M£5.89B
7 Day Performance8.41%-0.52%3.49%-0.07%
1 Month Performance2.16%3.86%16.14%2.36%
1 Year Performance44.75%-1.08%67.65%139.25%

Iofina Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IOF
Iofina
1.2728 of 5 stars
GBX 24.83
+7.9%
GBX 40
+61.1%
+35.1%£47.63M£57.65M993.0095News Coverage
High Trading Volume
TET
Treatt
0.4024 of 5 stars
GBX 279.58
-0.3%
GBX 266.67
-4.6%
-42.8%£164.82M£145.16M1,524.43350Dividend Increase
SYNT
Synthomer
2.445 of 5 stars
GBX 68.22
+1.5%
GBX 98.33
+44.1%
-66.9%£111.52M£1.89B-133.504,200News Coverage
HAYD
Haydale Graphene Industries
N/AGBX 0.70
+6.1%
N/A+158.9%£30.26M£3.61M-212.1267Positive News
WCH
Wilmcote Holdings plc (WCH.L)
N/AN/AN/AN/A£20.13MN/A-5.003
ITX
Itaconix
1.2752 of 5 stars
GBX 105
-4.5%
GBX 325
+209.5%
-23.1%£14.16M£8.55M-972.2217Gap Up
DCTA
Directa Plus
N/AGBX 9.50
+2.7%
N/A-19.6%£9.92M£7.17M-237.48187Gap Up
HDD
Hardide
N/AGBX 7.15
-1.4%
N/A+36.0%£5.64M£5.42M-1,787.5046
BIOM
Biome Technologies
N/AGBX 9.50
flat
N/A+58.3%£4.90M£5.75M-27.9427Gap Up
VRS
Versarien
N/AGBX 0.01
+8.3%
N/A-76.3%£781K£2.42M-3.9470Gap Down
ZED
Zenova Group
N/AGBX 0.21
flat
N/AN/A£762K£100K-27.3311

Related Companies and Tools


This page (LON:IOF) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners